<table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Intermediate Progenitor Cells</th> </tr> <tr> <td class="label">Category </td> <td>Neural Progenitors</td> </tr> <tr> <td class="label">Location </td> <td>Subventricular zone, subgranular zone of dentate gyrus</td> </tr> <tr> <td class="label">Cell Types </td> <td>TBR2+ intermediate progenitor cells</td> </tr> <tr> <td class="label">Division Type </td> <td>Symmetric and asymmetric division</td> </tr> <tr> <td class="label">Key Markers </td> <td>TBR2 (EOMES), TBR1, CUX2, PROX1</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0000826](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000826)</td> </tr> <tr> <td class="label">Condition</td> <td>Relationship to IPCs</td> </tr> <tr> <td class="label">Alzheimer's Disease</td> <td>Severely impaired neurogenesis</td> </tr> <tr> <td class="label">Parkinson's Disease</td> <td>Compensatory proliferation, limited regeneration</td> </tr> <tr> <td class="label">Huntington's Disease</td> <td>Reduced IPC proliferation</td> </tr> <tr> <td class="label">Stroke</td> <td>Increased IPC proliferation (endogenous repair)</td> </tr> <tr> <td class="label">Aging</td> <td>Declining IPC function</td> </tr> </table>
Introduction ...
<table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Intermediate Progenitor Cells</th> </tr> <tr> <td class="label">Category </td> <td>Neural Progenitors</td> </tr> <tr> <td class="label">Location </td> <td>Subventricular zone, subgranular zone of dentate gyrus</td> </tr> <tr> <td class="label">Cell Types </td> <td>TBR2+ intermediate progenitor cells</td> </tr> <tr> <td class="label">Division Type </td> <td>Symmetric and asymmetric division</td> </tr> <tr> <td class="label">Key Markers </td> <td>TBR2 (EOMES), TBR1, CUX2, PROX1</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0000826](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000826)</td> </tr> <tr> <td class="label">Condition</td> <td>Relationship to IPCs</td> </tr> <tr> <td class="label">Alzheimer's Disease</td> <td>Severely impaired neurogenesis</td> </tr> <tr> <td class="label">Parkinson's Disease</td> <td>Compensatory proliferation, limited regeneration</td> </tr> <tr> <td class="label">Huntington's Disease</td> <td>Reduced IPC proliferation</td> </tr> <tr> <td class="label">Stroke</td> <td>Increased IPC proliferation (endogenous repair)</td> </tr> <tr> <td class="label">Aging</td> <td>Declining IPC function</td> </tr> </table>
Introduction Intermediate progenitor cells (IPCs) are transit-amplifying neural progenitors that reside in the ventricular zone (VZ) and subventricular zone (SVZ) of the developing and adult brain. These cells represent a critical intermediate stage between neural stem cells (radial glia) and mature neurons, serving as the primary source of neuronal production during brain development and adult neurogenesis. In the context of neurodegeneration, IPCs have attracted significant attention due to their potential for endogenous repair mechanisms. [@englund2005]
Overview
Mermaid diagram (expand to render)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
[Cell Ontology (CL:0000826)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000826)
[OBO Foundry (CL:0000826)](http://purl.obolibrary.org/obo/CL_0000826)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
Molecular Biology
TBR2: The Defining Marker TBR2 (T-box brain 2, encoded by EOMES gene) is the canonical marker of intermediate progenitor cells[1]:
Transcription factor : Belongs to T-box family
DNA binding : Regulates gene expression during neuronal differentiation
Downstream targets : TBR1, NeuroD1, Prox1
Temporal expression : Transient between radial glia and postmitotic neurons
Gene Expression Profile IPCs express a distinctive combination of markers:
TBR2+ : Definitive IPC marker
CUX2 : Cut-like homeobox 2, cortical neuron specification
Sox2 : Maintained from neural stem cells
Pax6 : Transcription factor for cortical development
Neurogenin 2 : Proneural gene driving neuronal fate
Cell Cycle Properties IPCs have distinct cell cycle characteristics:
Shorter cell cycle : ~18-24 hours compared to radial glia (~30 hours)
Symmetric divisions : Expand IPC pool
Asymmetric divisions : Generate neurons directly
Limited proliferation : Typically 2-5 divisions before neuronal differentiation
Adult Neurogenesis
Subventricular Zone (SVZ) The SVZ is the largest neurogenic niche in the adult brain:
Location : Lateral wall of the lateral ventricles
Niche structure :
Type B cells (neural stem cells)
Type C cells (IPCs)
Type A cells (neuroblasts)
3.
Migration : Rostral migratory stream to olfactory bulb
Daily production : ~700 new neurons per day in mice
Subgranular Zone (SGZ) The SGZ in the dentate gyrus generates hippocampal neurons:
Location : Boundary between granule cell layer and hilus
Niche components :
Type 1 cells (radial glia-like)
Type 2 cells (IPCs)
Type 3 cells (neuroblasts)
3.
Target : Granule neurons in dentate gyrus
Daily production : ~700 new neurons per day in humans
Role in Neurodegeneration
Alzheimer's Disease Adult neurogenesis is significantly impaired in AD[2]:
Reduced proliferation : SVZ and SGZ show decreased IPC proliferation
Impaired differentiation : Reduced neuronal commitment
Aβ effects : Amyloid-beta directly inhibits neurogenesis
Tau pathology : NFT formation in neurogenic regions
Therapeutic potential : Enhancing neurogenesis may compensate for neuron loss
The decline in hippocampal neurogenesis correlates with cognitive decline in AD patients[3]. Strategies to enhance IPC function are being explored as potential therapeutic approaches.
Parkinson's Disease IPCs have relevance to PD through several mechanisms:
SVZ response : Increased IPC proliferation in early PD (compensatory)
Dopaminergic differentiation : Potential to generate dopamine neurons
Limited regeneration : Insufficient to replace lost neurons
alpha-synuclein effects : Pathology may spread to neurogenic niches
Therapeutic Applications IPCs represent attractive targets for regenerative therapies:
Cell replacement : Directed differentiation to specific neuronal types
Gene therapy : Genetic modification to enhance survival
Small molecules : Pharmacological activation of IPCs
Biomaterials : Scaffolds to support IPC transplantation
Aging Neurogenesis declines with age in both SVZ and SGZ:
Decreased IPC numbers : Reduced progenitor pool
Longer cell cycle : Slower proliferation
Reduced neuronal differentiation : Fewer new neurons
Vascular decline : Niche deterioration
Inflammatory environment : Increased cytokines inhibiting neurogenesis
Research Techniques
Identification
Immunohistochemistry : TBR2, CUX2 staining
In situ hybridization : Gene expression mapping
Single-cell RNA-seq : Transcriptomic profiling
lineage tracing : Cre-loxP fate mapping
Functional Studies
BrdU/EdU labeling : Proliferation assays
Electrophysiology : Recording from new neurons
Optogenetics : Circuit manipulation
Calcium imaging : Activity monitoring
Clinical Relevance
See Also
Subventricular Zone
[Dentate Gyrus](/brain-regions/dentate-gyrus)
[Adult Neurogenesis](/investment/adult-neurogenesis)
[Neural Stem Cells](/cell-types/neural-stem-cells)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Cell Types Indexcell-types)](/cell-types)
Pathway Diagram The following diagram shows the key molecular relationships involving Intermediate Progenitor Cells discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description